Sunshine Biopharma News

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Slilaty Steve N.

Mar 5 16:10 ET

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(5.3%)

Feb 23 16:06 ET

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(9.99%),Altium Growth Fund, LP EIN:(9.99%), etc.

Feb 21 16:32 ET

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(7.60%),Steven Boyd(7.60%)

Feb 14 15:57 ET

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Slilaty Steve N.

Feb 12 16:14 ET

Sunshine Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Beaudoin Marc

Feb 9 09:06 ET

Sunshine Biopharma | D: Filing D

May 17, 2023 13:30 ET

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities

Dec 2, 2022 06:01 ET

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Not Applicable(16.4%)

Nov 2, 2022 11:13 ET

Sunshine Biopharma | 3: Initial statement of beneficial ownership of securities-10% Owner Chamoun Malek

Oct 26, 2022 15:39 ET

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities

Jun 6, 2022 12:36 ET

Sunshine Biopharma | D: Filing D

Apr 29, 2022 14:13 ET

Sunshine Biopharma | D: Filing D

Mar 18, 2022 07:58 ET

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities

Feb 22, 2022 13:07 ET

Sunshine Biopharma | 3: Initial statement of beneficial ownership of securities-Director NATAN DAVID

Feb 18, 2022 15:25 ET

Sunshine Biopharma | 3: Initial statement of beneficial ownership of securities-Director Keller Andrew Mark

Feb 18, 2022 15:25 ET

Sunshine Biopharma | 3: Initial statement of beneficial ownership of securities

Dec 16, 2021 11:20 ET

Sunshine Biopharma | 3: Initial statement of beneficial ownership of securities

Dec 14, 2021 13:20 ET

Sunshine Biopharma | 3: Initial statement of beneficial ownership of securities

Dec 9, 2021 14:20 ET

Sunshine Biopharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Jul 29, 2021 16:45 ET